BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Class B Common Stock
Shares outstanding
5,071,025
Total 13F shares
18,297,158
Share change
-388,771
Total reported value
$6,935,982,346
Put/Call ratio
174%
Price per share
$379.12
Number of holders
463
Value change
-$192,100,378
Number of buys
200
Number of sells
276

Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2023

As of 30 Jun 2023, BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by 463 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,297,158 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Veritas Asset Management LLP, BROWN ADVISORY INC, STATE STREET CORP, ALLIANCEBERNSTEIN L.P., GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, WESTFIELD CAPITAL MANAGEMENT CO LP, and SOUTHEASTERN ASSET MANAGEMENT INC/TN/. This page lists 463 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.